Nephros (NEPH) Net Income Growth (1y) (2011 - 2026)
Nephros (NEPH) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.38% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -282.67% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -25.78% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 9.23% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 56.71% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -188.83% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 20.94% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -96.77% |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | -77.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.72% |
| Dec 31, 2025 | -82.97% |
| Sep 30, 2025 | 84.15% |
| Jun 30, 2025 | 182.01% |
| Mar 31, 2025 | 428.98% |
| Dec 31, 2024 | 158.52% |
| Sep 30, 2024 | 195.31% |
| Jun 30, 2024 | 31.52% |
| Mar 31, 2024 | 40.34% |
| Dec 31, 2023 | -382.17% |
| Sep 30, 2023 | 89.92% |
| Jun 30, 2023 | -8.21% |
| Mar 31, 2023 | 27.34% |
| Dec 31, 2022 | 59.31% |
| Sep 30, 2022 | -428.89% |
| Jun 30, 2022 | 65.33% |
| Mar 31, 2022 | 60.51% |
| Dec 31, 2021 | 56.63% |
| Sep 30, 2021 | 62.15% |
| Jun 30, 2021 | 30.73% |